These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Role of Pharmacogenomics in Opioid Prescribing. Wong AK; Somogyi AA; Rubio J; Philip J Curr Treat Options Oncol; 2022 Oct; 23(10):1353-1369. PubMed ID: 36001223 [TBL] [Abstract][Full Text] [Related]
7. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients. Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496 [TBL] [Abstract][Full Text] [Related]
8. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
17. Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project". O'Donnell PH; Danahey K; Jacobs M; Wadhwa NR; Yuen S; Bush A; Sacro Y; Sorrentino MJ; Siegler M; Harper W; Warrick A; Das S; Saner D; Corless CL; Ratain MJ Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):68-75. PubMed ID: 24616296 [TBL] [Abstract][Full Text] [Related]
18. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Lee YM; McKillip RP; Borden BA; Klammer CE; Ratain MJ; O'Donnell PH Pharmacogenet Genomics; 2017 May; 27(5):179-189. PubMed ID: 28267054 [TBL] [Abstract][Full Text] [Related]
19. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043 [TBL] [Abstract][Full Text] [Related]
20. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. Saulsberry L; Danahey K; Middlestadt M; O'Leary KJ; Nutescu EA; Chen T; Lee JC; Ruhnke GW; George D; House L; van Wijk XMR; Yeo KJ; Choksi A; Hartman SW; Knoebel RW; Friedman PN; Rasmussen LV; Ratain MJ; Perera MA; Meltzer DO; O'Donnell PH J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]